Dr. Tomasz Marek Wrzesinski, MS, Ph.D. is a Senior Bioinformatician at the Ardigen. He received his Ph.D. degree in 2016 from Adam Mickiewicz University in Poznan, Poland. The particular focus of his work was to detect transcriptomic changes in clear cell renal cell carcinoma tumors that correlate with clinical variables of these neoplasms using Illumina RNA-Seq technology. His scientific interests are especially, but not limited to, genomics and transcriptomics, i.e. resolving complex cellular networks, analyzing large datasets, and regulating of transcription.
Shortly after defending his Ph.D. thesis, in April 2016 he started working at EI where he is involved in studying the evolution, expression, and functionality of long non-coding transcribed sequences in Eukaryotes. A specific focus of the research is to better understand the impact of nucleotide variation within long non-coding RNAs on individual fitness